Navigation Links
Voices Against Brain Cancer Commends Researchers for the Identification of an Important Protein that May Give Insight to More Effective Glioblastoma Treatments
Date:11/1/2013

New York, NY (PRWEB) November 01, 2013

Voices Against Brain Cancer commends Washington University School of Medicine researchers for identifying a protein that may give scientists better insight into more effective treatments for glioblastoma patients.

According to an October 21, 2013 article published by Medical Xpress titled “New Clue to Aggressive Brain Tumors”, researchers at the Washington University School of Medicine in St. Louis, Missouri, identified a “biological marker” that may help scientists and doctors predict survival in patients who suffer from the most aggressive form of brain cancer – glioblastoma.

The protein, called F11R, is made by noncancerous cells. When F11R is present at higher levels, glioblastomas appear to be more aggressive. The noncancerous cells that make up the protein are called monocytes which are found within the tumor. Monocytes normally work to protect healthy brain cells; however they can provide critical support to tumor cells.

Senior author and the Donald O. Schnuck Family Professor of Neurology, David H. Gutmann, MD, PhD, and his team of collaborators have been studying how non-cancerous cells contribute to brain cancer formation and growth, with particular focus on the role of the F11R protein.

"When we checked for connections between F11R levels and the aggressiveness of brain tumors, we found more F11R-expressing monocytes in malignant tumors relative to their more benign counterparts," he says. "Moreover, even among the most malignant tumors we could use F11R to predict differences in patient survival rates."

Gutmann and his team are working to identify certain factors that are made by monocytes that help brain tumors grow in order to devise more effective glioblastoma treatments that can be used in the future. “The idea that we may be able to starve brain cancer cells of critical growth factors produced by noncancerous support cells may one day lead to the development of additional strategies to combine with conventional chemotherapy or radiation to combat brain tumors in children and adults.”

Michael Klipper, Chairman of Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, commends Gutmann and his team for their ongoing efforts. “It’s extremely comforting to see that the world’s most renowned scientists are working 24/7/365 to find an effective remedy to this terrible disease,” he says. “It gives everyone in the brain cancer community hope and a reason to believe that there will one day be a way to cure brain cancer.”

VABC has a wide variety of initiatives in place for brain cancer research, awareness and support. The organization’s research grants fund cutting-edge research programs that will have a monumental impact on the diagnosis and treatment of brain cancer. VABC currently funds research at several esteemed institutions such as Brookhaven National Laboratory, Cleveland Clinic, Columbia, Cornell, Duke, Harvard, John Hopkins, Memorial Sloan-Kettering and Yale, to name a few.

VABC's mission is to find a cure for brain cancer by advancing scientific research, increasing awareness within the medical community and supporting patients, their families and caregivers afflicted with this devastating disease.

For press inquiries, please contact: 5W Public Relations.

Read the full story at http://www.prweb.com/releases/cancer/news/prweb11261231.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Voices Against Brain Cancer Comments On Breakthrough Brain Surgery Technique
2. Redressing Past Wrongs: Changing the Common Rule to Increase Minority Voices in Research
3. Changing the common rule to increase minority voices in research
4. Voices Against Brain Cancer Comments on New Way for Cancer Treatments to Gain Access to the Brain
5. Voices Against Brain Cancer Discusses Recent Finding By Johns Hopkins Researchers Concerning Brain Tumor Treatments
6. Voices Against Brain Cancer Discusses Possible Breakthrough in Brain Cancer Treatment
7. Voices Against Brain Cancer Comments on New Technique Being Used by Surgeons that Lights Up Brain Tumors
8. Voices Against Brain Cancer Commends Brain Cancer Patient for Competing in Ironman Competitions
9. Voices Against Brain Cancer Comments on Discovery of Nano Drug That May Aid in Treatment of Brain Tumors
10. Voices Against Brain Cancer Commends Neuropsychologist and Team for Research on Cognitive Brain-Training for Cancer Survivors
11. Voices Against Brain Cancer Comments on Discovery of a Cause of Resistance to Therapy in Cases of Brain Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... 27, 2017 , ... Buzzies parent company, The TouchPoint Solution’s CEO and co-founder, ... and UBS’ Project Entrepreneur. Mayo will present her pitch about the lifestyle wearable devices, ... second annual venture competition ignites bold ideas by providing women access to the tools, ...
(Date:3/27/2017)... ... March 27, 2017 , ... American Veterinarian™, the leading multimedia ... medicine, announces the launch of Veterinarian’s Money Digest™, a business and financial resource ... of American Veterinarian™. , “We look forward to launching Veterinarian’s Money ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... products enables researchers to pursue the recent RNA methylation “gold rush” with their ... light of the newfound characteristics of N6-methyladenosine, or m6A , RNA methylation ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... According to ... prostate cancer, including all stages, is more than 95%. Once the cancer spreads to ... less than 30%. To find out how to avoid this latter group, tune in ...
(Date:3/27/2017)... ... March 27, 2017 , ... ?Grow Healthy Vending ... the pending litigation between itself and 1800 Vending DBA Healthy You Vending. (Civil ... am thrilled to announce that we have now reached a settlement agreement regarding ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 27, 2017  ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage ... early toxicology and efficacy studies. The company is harnessing ... specific protein, MAGE A, in an effort to find ... After 4 weeks of treatment in transgenic ... little toxicity in a full toxicology report of various ...
(Date:3/27/2017)... March 27, 2017  Sanderling Ventures, portfolio company, ... a division of Johnson & Johnson. Torax manufactures and ... treatment of gastro-esophageal reflux disease (GERD). The LINK ... technology and the procedure is currently available in ... Torax Medical was founded by Sanderling Ventures, Mayo ...
(Date:3/27/2017)... March 27, 2017 BioLineRx Ltd. (NASDAQ/TASE: ... announced today that AGI-134, an immunotherapy for the treatment of ... Ltd., will be featured at the upcoming American Association ... Washington, DC to be held on April 1-5, ... ...
Breaking Medicine Technology: